Cigarette Smoker Clinical Trial
Official title:
Validation of Biomarkers of Exposure and Host Response
This study will evaluate biomarkers measured in exhaled breath condensate (EBC) to assess clinical strategies of harm reduction. It will take advantage of a recently developed device that permits collection of exhaled breath condensate reproducibly, with minimal subject effort and with no oral contamination. Samples from asymptomatic smokers before and after inducing a change in their smoking habit (cessation or reduction) with the aid of partial nicotine replacement.
The proposed study will evaluate biomarkers measured in exhaled breath condensate (EBC) for the purpose of assessing clinical strategies of harm reduction. It will take advantage of a recently developed device that permits collection of exhaled breath condensate reproducibly, with minimal subject effort and with no oral contamination. The major goal of the trial is to provide evidence to validate biomarkers in EBC. This will be accomplished by collecting samples from asymptomatic smokers before and after inducing a change in their smoking habit (cessation or reduction) with the aid of partial nicotine replacement. Measures to be made in EBC include H2O2, the most widely explored biomarker in this "body" fluid. Methods that reliably can quantify levels in normal non-smokers and in asymptomatic smokers will be used. Two fold increases in smokers have been reported by in several reports and confirmed in preliminary data by the investigators. In addition, other biomarkers of oxidant stress: TBARs, 8-isoprostane and nitrotyrosine will be quantified using standard methods. Biomarkers quantified in EBC will be assessed for reliability (i.e. reproducibility and for sensitivity) to change and for validity (by comparison to clinically defined endpoints and previously validated measures of exposure). Reproducibility will be assessed by making repeated measurements in the same subjects on different occasions. Sensitivity to change will be assessed by comparing values before and after changing smoking habit. Finally, the validity of the biomarkers will be assessed by comparing them to previous measures of smoke exposure (CO, NNAL and NNAL-glc) and to clinically defined endpoints: symptoms, the St. George's Respiratory Questionnaire and post bronchodilator lung function. With regard to the latter measures, preliminary data indicate that symptoms can be detected in "asymptomatic" smokers and that these can change with a harm reduction strategy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03691350 -
Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs
|
Early Phase 1 | |
Completed |
NCT01967082 -
APPSPIRE App in Preventing Students From Smoking
|
N/A | |
Recruiting |
NCT03865472 -
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
|
N/A | |
Active, not recruiting |
NCT02271919 -
Varenicline and Combined NRT for Smoking Cessation
|
Phase 4 | |
Withdrawn |
NCT03668769 -
Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
|
N/A | |
Completed |
NCT02575885 -
Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers
|
N/A | |
Completed |
NCT04060446 -
Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
|
||
Completed |
NCT00941395 -
Enhanced Smoking Cessation for University Students
|
N/A | |
Recruiting |
NCT03199651 -
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
|
N/A | |
Recruiting |
NCT03824535 -
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
|
Phase 2 | |
Completed |
NCT00850954 -
Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households
|
N/A | |
Active, not recruiting |
NCT02697227 -
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
|
N/A | |
Completed |
NCT03669120 -
Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking
|
N/A | |
Completed |
NCT00948129 -
Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers
|
N/A |